Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease

Author： Böhm Felix Jensen Jens Svane Bertil Settergren Magnus Pernow John

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.86, Iss.11, 2008-11, pp. : 745-751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-activated Receptor-γ(PPARγ) Agonist Improves Coronary Artery Endothelial Function in Diabetic Patients with Coronary Artery Disease

By Yu J Zhang Z Li Z Feng X He L Liu S Mao J Wang G Wang X

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 86-94

Field House Publishing

Access to resources Recommend Favorite

Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease

By Bulut Daniel Becker Vanessa Mügge Andreas

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 4, 2011-04 ,pp. : 239-244

NRC Research Press

Access to resources Recommend Favorite

Perindopril versus Angiotensin II Receptor Blockade in Hypertension and Coronary Artery Disease: Implications of Clinical Trials

By Brady Adrian J.B.

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 149-161

Adis International

Access to resources Recommend Favorite

Folic acid + cyanocobalamin improves coronary endothelial function

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Effect of Beta-Blockade on Heart Rate and VO₂ Kinetics during Recovery in Patients with Coronary Artery Disease

Heart Drug, Vol. 2, Iss. 2, 2002-06 ,pp. : 69-74

Karger

Access to resources Recommend Favorite